骨髓真空化到治疗策略:在维克萨斯综合征管理中演变的范式
Mahmoud I Elbadry1, Mohamed Mabed2
1Department of Internal Medicine, Division of Haematology, Faculty of Medicine, Sohag University, Sohag, 82524, Egypt.
Current research in translational medicine
|August 10, 2025
概括
维克萨斯综合征是一种严重的成人发作的炎症性疾病,由UBA1基因突变引起,导致慢性炎症和不良预后. 目前的治疗方法是支持性的,干细胞移植是唯一的治疗方法,但新的向疗法显示出希望.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 维克萨斯综合征是一种严重的成人发病的自身炎症性疾病,由UBA1基因中获得的体质突变引起.
- 它的特点是慢性系统性炎症,克隆性血液形成,细胞衰竭,以及血液恶性瘤的风险增加.
- 这种情况呈现出严峻的预后,通常因感染,骨髓衰竭或血栓事件而复杂化.
研究的目的:
- 审查当前的治疗策略,治疗挑战和VEXAS综合征的最新进展.
- 突出需要有针对性的疗法和改进的生物标志物,以实现个性化治疗.
主要方法:
- 对VEXAS综合征现有文献的综述.
- 诊断标准的分析,包括UBA1遗传测试和骨髓检查.
- 评估当前和研究中的治疗方法.
主要成果:
- 诊断依赖于UBA1基因分析和特征性骨髓真空化.
- 目前的治疗方法包括支持性护理,抗炎药物 (例如,类固醇,JAK抑制剂) 和低甲基化剂.
- 全基性造血干细胞移植 (HSCT) 是唯一的治愈选择,但具有显著的毒性.
结论:
- 针对NLRP3炎症体和蛋白质体通路的研究疗法显示出潜力.
- 由于基因型-表型变异性和生物标志物不足,缺乏标准化的治疗范式.
- 针对性策略的紧急开发对于改善VEXAS综合征患者的治疗结果至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cystic Fibrosis: Management
224
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
224


